NHÌN LẠI VỀ ĐIỀU TRỊ MIỄN DỊCH TRONG UNG THƯ

Abstract

Immunotherapy has emerged as a new therapy in cancer treatment, offering a powerful alternative to traditional treatments such as chemotherapy and radiotherapy. Its role is important today, especially in cancers where conventional treatments have limited effectiveness. Immune checkpoint inhibitors, such as pembrolizumab and nivolumab, have revolutionized the treatment landscape of cancer groups with poor prognosis by blocking inhibitory pathways, allowing the immune system to recognize and attack cancer cells more effectively. These therapies have demonstrated significant success across a variety of cancer types, including melanoma, lung cancer, and renal cell carcinoma, significantly improving survival rates and quality of life. life for many patients. Additionally, adoptive cell transfer therapies, such as CAR T-cell therapy, have shown unprecedented responses in several hematological malignancies, further expanding treatment options. immunotherapy. In summary, the role of immunotherapy in cancer today is transformative, offering new treatment avenues and a ray of hope for patients with advanced or metastatic cancer. As research continues to advance, immunotherapy is poised to play an increasingly central role in the future of cancer care.